Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Transactions related to share buy-back program (week 24, 2026)
Company announcement No. 25 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 24, 2026) Copenhagen, Denmark, June 15, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
Pharma Mar, S.A. (PHMMF) Shareholder/Analyst Call Transcript
Pharma Mar, S.A. (PHMMF) Shareholder/Analyst Call June 15, 2026 8:00 AM EDT José Martinez-Losa - Head of Capital Markets & Investor Relations Pascal Besman - Senior Vice President of Strategic Development José Antonio…
Why Indian pharma industry is relieved after US-Iran deal
The ongoing war had severely disrupted maritime transit through the Strait of Hormuz, affecting the supply of key petrochemical inputs. The blockade caused a major shortage of propylene, an essential feedstock for producing pharmaceutical-grade…
Personalization in Pharma marketing: Beyond segments
Pharma personalization is about leveraging approved data, content modules, channel signals and consent to shape what a healthcare professional and/or patient audience is going to get next. It is not just a static group like, for example…
When they arrive at Cannes, pharma companies will be ready to show AI receipts
AI will once again be nearly impossible to avoid at the Cannes Lions International Festival of Creativity. Yet this year, simply putting AI in a slide presentation won't cut it. When the advertising industry descends on Cannes from June 22 through…
Why Is Rhythm Pharma Stock Jumping Today? - Rhythm Pharmaceuticals (NASDAQ:RYTM)
The six-month data shared on Saturday showed improvements in body mass index, body composition, hyperphagia, and behavioral measures. The company presented the findings at the Endocrine Society's Annual Meeting, ENDO 2026. The trial enrolled 18…
These 8 pharma and healthcare stocks may be in focus on Monday
Dr. Reddy's Laboratories Ltd, along with its subsidiaries, has announced the first-to-market launch of Bosutinib Tablets 400mg, a generic equivalent of Bosulif, in the US, expanding its oncology portfolio and reinforcing its commitment to improving…
Australian pharma giant Sigma quits Boots takeover talks
Australian pharmacy giant Sigma has walked away from talks over a £7.5bn private takeover of Boots, renewing hopes that the high street pharmacy could float in London. The Australian firm said on Monday that a deal with Boots would not meet…
Royalty Pharma PLC $RPRX Shares Bought by Entropy Technologies LP
Entropy Technologies LP boosted its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 171.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 88,652 shares of the biopharmaceutical…
Moon Rabbit Expands Client Roster and Senior Leadership, Garners More Industry Recognition
Recent milestones reflecting the agency's continued growth and momentum include: Named strategic/creative agency of record by LEO Pharma, Inc. for SPEVIGO, supporting the brand in the U.S. and globally Named agency of record for a global biotech…
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Rating of 'Moderate Buy' by Analysts
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) has earned a consensus rating of 'Moderate Buy' from the twenty-six research firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell…
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the…
Stock markets surge 1,172 pts as US-Iran reach peace deal
Stock market benchmark indices Sensex and Nifty surged in early trade on Monday, mirroring a rally in global equities and a sharp decline in crude oil prices, after the US and Iran finalised a deal to end their 107-day war. The 30-share BSE Sensex…
Indian Stock Market Rallies: Sensex, Nifty Jump on US-Iran Peace Deal & Crude Oil Price Decline
Indian stock markets, including the Sensex and Nifty, experienced a significant surge following a global rally and a sharp decline in crude oil prices, as the US and Iran finalised a peace deal to end their conflict and reopen the Strait of Hormuz.
Nifty Prediction Today - June 15, 2026: Nifty futures: Surpasses a barrier
Nifty 50 opened with a considerable gap-up at 23,985 today versus last week's close of 23,623. The index is now hovering around 23,950, up about 1.4 per cent. The advance/decline ratio of the index is now 46/4, showing a strong positive bias.
Receive a Daily briefing on Pharma Industry News
Get Started